Stockwinners Market Radar for January 31, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:31 EST Cathie Wood's ARK Investment bought 105K shares of Block today

19:32 EST Equifax to acquire Efficient Hire - Equifax "announced that it has signed a definitive agreement to acquire Efficient Hire, a provider of cloud recruiting, onboarding and HR management solutions. This acquisition will enable Equifax Workforce Solutions to bring employers more of the services and insights they need to help them manage amidst a rapidly changing hiring and employment landscape. The transaction is subject to customary closing conditions and is expected to close in February 2022. The acquisition is not anticipated to have a material impact on Equifax's 2022 financial results."

18:30 EST Hudson Global CEO buys $43K in common stock - In a regulatory filing, Hudson Global disclosed that its CEO Jeffrey Eberwein bought 1.5K shares of common stock on January 31st in a total transaction size of $43.2K.

18:17 EST Rogers Communications names Glenn Brandt CFO - Rogers Communications announced that Glenn Brandt has been appointed Chief Financial Officer, effective today. Glenn brings 35 years of financial management experience to the role, including 30 years of career progression within Rogers across Treasury, Investor Relations and Corporate Development and most recently served as Senior Vice President, Corporate Finance. "Glenn is a highly regarded leader with deep industry experience as well as extensive experience in corporate finance, including raising capital and working with credit agencies," said Tony Staffieri, President and CEO. "His strong leadership as CFO will be integral as we work to successfully come together with Shaw, drive growth across our business, and maintain the strong balance sheet needed to invest for the future." Paulina Molnar will work with Glenn to ensure an effective transition of CFO responsibilities. "I want to thank Paulina for her terrific work as Interim CFO and look forward to her continued leadership across our organization as SVP Controller and Risk Management," added Mr. Staffieri.

18:01 EST SSR Mining intends to increase 2022 base dividend by 40% - Rod Antal, President and CEO, said, "2021 was a year of operational and financial outperformance for SSR Mining as we showcased the quality and resiliency of our globally diversified business in an inflation-challenged landscape. We successfully delivered production at the top end of our guidance range and concurrently beat our reduced AISC guidance. This outperformance allowed SSR Mining to generate more than $400 million of free cash flow and drove peer leading shareholder returns of nearly $200 million over the course of the year, resulting in a 5%+ yield. We also executed a number of strategic transactions which increased our presence in core jurisdictions, while divesting non-core assets. When completed, these transactions will cumulatively realize over $235 million in total consideration for SSR Mining. As we look to the year ahead, we expect to deliver another year of stable and consistent production with a cost profile and capital intensity that ensures continued strong free cash flow generation and capital returns. While we were able to manage and offset inflationary pressures in 2021, we expect cost increases across the portfolio in 2022. These pressures reflect increases in consumables, energy prices, and wages in addition to capital deferrals from 2021. Despite these sector-wide inflationary headwinds, we intend to increase our 2022 base dividend by 40%, and will continue with our share buyback program implemented in 2021. We also look forward to beginning to delineate the value associated with some of our recent brownfield exploration success in our upcoming technical reports. As promised, in 2023 and 2024 we expect to maintain a stable production profile in excess of 700,000 gold equivalent ounces. The steady three-year production profile highlights the quality of our existing portfolio, and we expect to illustrate opportunities for longer-term step-change growth through our ongoing exploration programs."

17:59 EST SSR Mining reports 2021 production of 794,456 gold equivalent ounces - SSR Mining is pleased to announce full year 2021 production and costs as well as the company's outlook for 2022 to 2024. In 2021, SSR Mining's four operating assets produced 794,456 gold equivalent ounces, delivering strong fourth quarter performance of 211,140 gold equivalent ounces and approaching the top end of the company's guidance range of 720,000 to 800,000 gold equivalent ounces.

17:49 EST German American Bancorp raises quarterly dividend to 23c from 21c per share - Payable on February 20 to shareholders of record as of February 10.

17:36 EST Capital Southwest raises dividend to 48c from 47c - On January 26 the Board declared a quarterly dividend of $0.48 per share for the quarter ended March 31.

17:31 EST Lockheed Martin awarded $684.95M Navy contract modification - Sikorsky Aircraft, a Lockheed Martin company, was awarded a $684.95M fixed-price incentive modification to a previously awarded contract. This modification exercises options for the production and delivery of nine low rate initial production, Lot 6, CH-53K heavy lift aircraft, as well as associated aircraft programmatic and logistical support. Work is expected to be completed in July 2025. FY22 aircraft procurement funds in the amount of $684.95M will be obligated at time of award, none of which will expire at the end of the current fiscal year. The Naval Air Systems Command is the contracting activity.

17:29 EST Northrop Grumman to compete for orders on $750M Air Force contract - Northrop Grumman and Global Military Products will compete for each order of the $750M firm-fixed-price contract for special ammunition and weapons systems. Bids were solicited via the internet with 10 received. Work locations and funding will be determined with each order, with an estimated completion date of January 30, 2027. U.S. Army Contracting Command is the contracting activity.

17:14 EST Kaival Brands receives noncompliance notification from Nasdaq - Kaival Brands announced that it has received notification from Nasdaq notifying the company that it is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550 because the closing bid price of the company's common stock was below $1.00 per share for 30 consecutive trading days. The notification does not impact the listing of the company's common stock on Nasdaq at this time.

17:04 EST Four Corners Property Trust acquires Truist Bank outparcel property for $1.1M - Four Corners Property Trust announced the acquisition of an outparcel property leased to Truist Bank for $1.1M. The property is located in a strong retail corridor in North Carolina and is corporate-operated under a triple net lease with 6 years of term remaining. The transaction was priced at a cap rate in range with previous FCPT transactions.

17:01 EST Summit Hotel Properties announces retirement of COO Craig Aniszewski - Summit Hotel Properties announced that Craig Aniszewski, its executive VP and COO, plans to retire from the company on March 1. Jonathan PStanner, the company's CEO, noted, "We are fortunate to have two highly qualified and experienced individuals being promoted as part of the succession plan for Craig. I look forward to continuing to work closely with Larry Trowbridge and Greg James to ensure a successful and seamless transition."

16:55 EST Westwater Resources receives NPDES Permit - Westwater Resources announced it has received an NPDES Permit. The permit is required to commence site grading at the Coosa Graphite Processing Facility located near Kellyton, Alabama. The permit has been issued by the State of Alabama under the National Pollutant Discharge Elimination System, or NPDES, to ensure Westwater's construction efforts comply with the Federal Clean Water Act as it relates to regulated disturbances and any stormwater runoff from the Coosa Graphite Plant site. The permit, when coupled with the company's best management practices, allows Westwater to commence site grading activities at the Coosa Graphite Plant. Site grading activities, anticipated to begin in March, are those required to prepare for building construction.

16:41 EST Mobility solutions company Xos spikes over 10% in post-market trading - Shares of mobility solutions company Xos are up an additional 10% in after-hours trading, after a 11% move in regular trading, to $2.50 per share after announcing preliminary results for the quarter ended December 31: Deliveries of 32 units; Revenue of $3.1M. These results compare to the previously announced fourth quarter outlook of 15 to 25 unit deliveries and revenues of $1.7 to $3.0M provided in the Company's third quarter 2021 earnings release from November 11. "Our ramp up in deliveries as we moved through the fourth quarter at both our Byrdstown and Monterrey facilities demonstrates our ability to fulfill customer orders for our zero-emission vehicles and powertrains in the face of a global supply chain disruption," said Dakota Semler, Xos' Chief Executive Officer. "

16:39 EST Mexico's FES, Sempra Infrastructure sign MOU for development of natgas projects - Mexico's Federal Electricity Commission, represented by its General Director Manuel Bartlett Diaz, and Sempra Infrastructure, a subsidiary of Sempra, represented by Tania Ortiz Mena, President of Sempra Infrastructure for Mexico, signed a non-binding memorandum of understanding for the development of important proposed projects, including Vista Pacifico LNG, a natural gas liquefaction project in Topolobampo, Sinaloa; a natural gas regasification project in La Paz, Baja California Sur; and the resumption of operations of the Guaymas-El Oro pipeline in Sonora. The development of these projects would allow CFE to optimize excess natural gas and pipeline capacity from Texas to Topolobampo in order to increase its natural gas supply to its power plants in Baja California Sur, to advance President Andres Manuel Lopez Obrador's commitment to supply the state with low-cost electricity and lower-emission fuels, and to promote economic growth and development of the region, with a view toward strengthening CFE's position in global LNG markets. The MOU also addresses the return to service of the Guaymas-El Oro pipeline in Sonora through a proposed re-routing based on mutual understanding between the Yaqui community and CFE through continued respectful dialogue. Through this new route, CFE would be able to supply natural gas to industrial, commercial and residential markets in the Pacific Coast of Mexico, Baja California Sur, as well as the Vista Pacifico LNG facility.

16:37 EST BJ's Restaurants appoints Marriott executive to board - BJ's Restaurants (BJRI) announced the appointment of Julius Robinson to the company's board of directors as an independent director, effective January 28. Additionally, Robinson will serve as a member of the compensation committee of the board. The appointment of Robinson brings the total number of the company's board members to thirteen. Robinson currently serves as the chief sales and marketing officer for the United States and Canada at Marriott (MAR).

16:34 EST Enerpac Tool announces CFO transition plan - Enerpac Tool Group announced that Rick Dillon, who has served as the company's Executive Vice President and CFO since 2016, will depart from the Company to pursue new opportunities. To ensure a smooth transition, Dillon will remain as CFO through April 30 or such later date as Dillon and the Company may mutually agree. The Company has initiated a comprehensive search to identify Enerpac's next CFO, and has retained a leading executive search firm to assist with the process. The search process will consider both internal and external candidates for the role.

16:33 EST Wordle to join New York Times Games - Wordle, Josh Wardle's popular daily word game, is joining The New York Times's portfolio of original puzzle games, The New York Times said on its website. At the time it moves to The New York Times, Wordle will be free to play for new and existing players, and no changes will be made to its gameplay. Wordle was acquired for an undisclosed price in the low-seven figures.

16:31 EST Steel Dynamics completes acquisition of 45% interest in New Process Steel - Steel Dynamics announced the completion of the acquisition of a minority equity interest in New Process Steel, L.P. New Process Steel is a metals solutions and distribution supply-chain management company headquartered in Houston, Texas. "This minority equity interest enables us to expand our exposure to value-added manufacturing opportunities, while continuing to serve our other long-standing flat roll steel customer needs." stated Mark D. Millett, Chairman and CEO. "New Process Steel has a reputation for high-quality standards and strong customer relationships. With Richard Fant and the New Process leadership team at the helm, we believe New Process will have a number of opportunities for value-added manufacturing growth. Steel Dynamics' focus remains on providing the highest quality steel and service to all of our customers, while creating innovative supply-chain solutions."

16:30 EST Accenture names Manish Sharma as COO, Jo Deblaere to retire - Accenture announced changes to its executive leadership team, naming a new COO and a new group chief executive of its Operations service. Each of these leaders exemplify Accenture's Leadership Essentials. Manish Sharma has been named chief operating officer, effective March 1, 2022, with responsibility for leading the company's business operations and executing business strategy, protecting the company's people and infrastructure and ensuring operational excellence, which includes the ongoing digital transformation of Accenture. Sharma most recently served as group chief executive - Operations. Jo Deblaere, who has served as chief operating officer since 2009, will continue in the position until March 1, 2022, and plans to retire on September 1, 2022. Yusuf Tayob has been named group chief executive - Operations, effective March 1, 2022. Currently, Tayob is market unit lead for the US Midwest.

16:29 EST United States Lime & Minerals increases quarterly dividend to 20c per share - The company announced that the board of directors has declared an increased regular quarterly cash dividend of 20c per share on the company's common stock. This dividend is payable on March 18 to shareholders of record at the close of business on February 25.

16:22 EST ContextLogic names Vijay Talwar CEO - ContextLogic (WISH) announced the appointment of Vijay Talwar as Chief Executive Officer and a member of the company's Board of Directors, effective February 1, 2022. Talwar succeeds Wish's Founder and former CEO, Piotr Szulczewski, who will continue to serve the company as a member of the Board. Talwar recently served as CEO of Foot Locker's (FL) Europe, Middle East & Africa business. "Wish has all the ingredients to be a true leader in the ecommerce space - a great product, an engaging and entertainment-driven social platform, a strong user base, and a world-class team that is highly motivated to deliver on the turnaround plan," said Mr. Talwar. "I am eager to apply my own experience within the retail and ecommerce space to further refine our focus and put the business back onto a path of growth. I firmly believe the best years for Wish are right ahead of us."

16:19 EST Apollo Global to make $760M equity investment in Legendary Entertainment - Apollo and Legendary Entertainment announced that funds managed by Apollo affiliates have agreed to make a $760M equity investment in Legendary, a global media company led by CEO Joshua Grode that develops, produces, distributes and finances major motion picture and TV projects across multiple platforms and maintains leading comic book, VR, licensing and merchandising divisions. The minority investment comes as Legendary concluded its most profitable year to-date in 2021 and with a strong balance sheet is ramping up production on a large slate of new films and TV series, in the United States and internationally.

16:17 EST Envista and PDS extend implant and imaging commercial relationship - Envista Holdings and Pacific Dental Services, or PDS, announced the extension of their implant and imaging commercial relationship for an additional five years, and the expansion of this relationship to include Envista's Spark clear aligners. Over the past several years, PDS and Envista have invested resources to expand implant treatment capabilities to each of PDS' supported practices, training hundreds of clinicians, and creating a network that offers the latest tooth replacement solutions from Nobel Biocare.

16:15 EST Oil-Dri Corporation of America to increase price of cat litter products - Oil-Dri Corporation of America announced that it will increase prices for its cat litter products effective April 1. These pricing actions will apply to branded and private label cat litter items sold within the United States. The company continues to experience substantial increases in freight, packaging, materials, natural gas, and non-fuel manufacturing costs, all of which are key components of its cat litter products.

16:12 EST Woodward increases quarterly dividend 17% to 19c per share - Woodward announced that its Board of Directors approved a dividend of 19c per share, up from the prior quarter's dividend of 16.25c per share. The dividend will be payable on March 7, 2022, for stockholders of record as of February 21, 2022.

16:11 EST PotlatchDeltic says 2022 off to 'great start' with surge in lumber prices - "2022 is off to a great start with the recent surge in lumber prices benefitting both our Timberlands and Wood Products businesses. We expect housing-related fundamentals that drive demand in our business to remain favorable and we continue to expect lumber prices will remain higher than long-term averages. We continue to monitor the pandemic and the trend in mortgage rates and their impact on lumber demand and our business. During 2022, we expect to harvest approximately 6.1 million tons in our Timberlands segment, ship around 1 billion board feet in lumber, and sell about 13,500 rural acres and 165 residential lots in our Real Estate Segment," stated Mr. Cremers.

16:08 EST Floor & Decor to open Monona, Wisconsin store on February 7 - Floor & Decor will expand its nationwide footprint when it opens the doors to its newest location in Monona, Wisconsin on February 7, 2022. The 80,000 square-foot Floor & Decor warehouse store and design center will open with a team of about 50 full-time and part-time associates led by Zach Klein, the new store's Chief Executive Merchant. "Floor & Decor is thrilled to open our doors in Monona, our first store in the Madison market," said Klein. "We are excited to introduce both Professional customers, as well as Homeowners, to our one-stop solution for their flooring needs with an extensive selection of in-stock, trend-right flooring options. We offer unmatched service and quality flooring at unbeatable prices. With our free design services, we look forward to helping every customer turn their vision into reality."

16:07 EST Laird Superfood names Jason Vieth as new CEO - Jason Vieth has been appointed President and CEO, replacing Paul Hodge, Jr., who previously announced his desire to step down from the CEO role. Mr. Vieth's most recent position was as Executive Vice President of Sovos Brands, where he managed the Breakfast and Snacks Group.

16:06 EST Electronic Arts names Chris Suh as new CFO - Electronic Arts (EA) named Chris Suh the company's new CFO, effective March 1. He will replace Blake Jorgensen, who previously announced he is stepping down after nearly a decade of financial leadership at Electronic Arts. Mr. Jorgensen will remain with the company until the summer to assist with the transition and special projects. Mr. Suh joins Electronic Arts from Microsoft (MSFT), where he currently serves as Corporate Vice President and Chief Financial Officer of the Cloud + AI group.

16:04 EST Sanmina reports Q1 adjusted operating margin 5.0%, GAAP operating margin 4.6%

15:45 EST Meridian Bank announces special dividend of $1.00 per share - On January 27, the Board of Directors declared a quarterly cash dividend of 20c per common share, along with a special dividend of $1.00 per share, both payable February 21 to shareholders of record as of February 14.

13:50 EST Boeing reports launch of 777-8 freighter, order for up to 50 from Qatar Airways - Boeing announced the launch of the new 777-8 Freighter and expanded its 777X and freighter families of jetliners with an order for up to 50 aircraft from Qatar Airways, the company confirmed in a press release. "Qatar Airways will be the 777-8 Freighter launch customer with a firm order for 34 jets and options for 16 more, a total purchase that would be worth more than $20 billion at current list prices and the largest freighter commitment in Boeing history by value. The order also supports hundreds of U.S. suppliers from across 38 states, will sustain more than 35,000 U.S. jobs, and provide the American economy with an annual estimated economic impact of $2.6 billion during the contract's delivery period," Boeing stated. As part of today's agreement, Qatar Airways will convert 20 of its 60 777X family orders to the 777-8 Freighter. Qatar Airways is also ordering two current 777 Freighters, Boeing said. Boeing and Qatar Airways also signed a Memorandum of Understanding for a firm order of 25 737-10 aircraft and purchase rights for 25 additional airplanes. The total value of this 737-10 commitment is nearly $7 billion at current list prices. "Qatar Airways very much looks forward to adding the 737-10 to its fleet, with this new variant of the 737 being ideally suited to our short-haul network, allowing us an opportunity to further enhance our product offering for our customers, modernize our fleet and operate the most efficient aircraft in its category," said Qatar Airways Group CEO Akbar Al Baker.

13:31 EST Lyell will be 'breakthrough company' in cell therapy space, CEO says

13:31 EST Lyell guided INDs 'on track,' CEO Liz Homans tells The Fly

13:31 EST Lyell CEO tells The Fly market opportunity for technology 'much higher than $1B'

13:22 EST Sony Group trading resumes

13:03 EST General Dynamics to start work on $518M global logistics contract - General Dynamics Information Technology announced that it has received a $518M task order award from the U.S. Army Communications Electronics Command to provide logistics, sustainment and maintenance services for joint U.S. and coalition forces worldwide within the Army Field Support Brigade regions. The task order was provided under the Responsive Strategic Sourcing for Services Multiple Award indefinite delivery, indefinite quantity contract awarded in April 2021 to a General Dynamics joint venture including GDIT, General Dynamics Mission Systems, General Dynamics Ordnance and Tactical Systems and General Dynamics Land Systems. The Government Accountability Office announced in December that work could start following the dismissal of two contract award protests.

12:53 EST Sony Group trading halted, news pending

12:08 EST Boeing says U.S.-Russia relations creating adverse climate for its business - In a regulatory filing, Boeing said that the current status of U.S.-Russia relations is creating an adverse climate for its business. "The U.S. Government continues to impose and/or consider imposing sanctions on certain businesses and individuals in Russia," the company said. "We continue to monitor and evaluate additional sanctions and export restrictions that may be imposed by the U.S. Government and any responses from Russia that could directly affect our supply chain, business partners or customers. We also continue to support the 737 MAX return to service in Russia." The planemaker added that the state of U.S.-China relations remains a "significant watch item."

12:02 EST Deluxe chosen as exclusive provider of checks to The Bradford Exchange - Deluxe has been selected by The Bradford Hammacher Group to be the exclusive provider of consumer and business checks to The Bradford Exchange.

12:01 EST Tidewater falls -8.6% - Tidewater is down -8.6%, or -$1.33 to $14.18.

12:00 EST TDCX rises 18.8% - TDCX is up 18.8%, or $2.52 to $15.89.

12:00 EST SQZ Biotechnologies rises 21.0% - SQZ Biotechnologies is up 21.0%, or $1.39 to $8.01.

11:06 EST Moderna receives FDA approval for SPIKEVAX COVID-19 vaccine - Moderna announced the U.S. Food and Drug Administration has approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older. The FDA based its decision on the totality of scientific evidence shared by the Company in its submission package, which included follow-up data from the Phase 3 COVE study showing high efficacy and favorable safety approximately six months after the second dose. Moderna also submitted manufacturing and facilities data required by the FDA for licensure. SPIKEVAX has received approval by regulators in more than 70 countries.

11:02 EST Orphazyme appoints Anders Vadsholt as CEO - Orphazyme announces that CEO Christophe Bourdon will resign from his position as CEO at Orphazyme A/S to take on the role as CEO of LEO Pharma A/S. Effective April 1, 2022, CFO Anders Vadsholt, will be appointed CEO of Orphazyme.

10:45 EST GreenLight Biosciences, Germains Seed partner for dsRNA seed treatment - GreenLight Biosciences and Germains Seed Technology announced a research partnership agreement that could lead to the first commercial use of RNA as a seed treatment to control crop diseases and offer options to farmers looking for innovative solutions. Through the partnership, the two companies will explore synergies between Germains' seed priming and coating technologies and GreenLight's dsRNA expertise and ability to cost-effectively scale manufacturing to protect vegetable crops. In October 2021, GreenLight announced that the company had achieved, for the first time ever, effective field control of fungal pathogens using double-stranded RNA. In 2022, GreenLight anticipates receiving U.S. regulatory approval of its RNA-based product for controlling the Colorado potato beetle and intends to submit its honeybee health solution to the U.S. Environmental Protection Agency. The company has seven agricultural products in development with an addressable market of $6 billion that it plans to launch by 2026.

10:29 EST FA approves Roche's Tecentriq as lung cancer adjuvant - The Food and Drug Administration said it approved Roche's Tecentriq for adjuvant treatment following resection and platinum-based chemotherapy in patients with stage II to IIIA non-small cell lung cancer whose tumors have PD-L1 expression on greater than or equal to1% of tumor cells, as determined by an FDA-approved test. The FDA also approved the Ventana PD-L1 Assay (as a companion diagnostic device to select patients with NSCLC for adjuvant treatment with Tecentriq. Reference Link

10:05 EST Lockheed Martin: LMXT strategic tanker aircraft to be made in Alabama, Georgia - Lockheed Martin (LMT) announced the LMXT strategic tanker aircraft will be manufactured in Mobile, Alabama, and Marietta, Georgia. Introduced in September 2021, the LMXT is Lockheed Martin's offering for the U.S. Air Force's KC-Y "Bridge Tanker" Program competition. The company said, "The LMXT represents the newest chapter in Lockheed Martin's 60-plus year history of producing and delivering tanker and large aircraft for the U.S. Air Force, U.S. Marine Corps, U.S. Navy and multiple operators around the world. Built on the combat-proven design of the Airbus (EADSY) A330 Multi Role Tanker Transport, the LMXT leverages known performance and capability insights from the strategic tanker of choice used by 14 nations around the world to currently refuel fighter, transport and maritime patrol aircraft for the U.S. and allied partners." With Lockheed Martin as the prime contractor, the LMXT will be built in two phases: Phase 1: The LMXT is first produced as an A330 airliner at Airbus' Mobile, Alabama, facility, which is where Airbus A320 and A220 commercial airliners are built, beginning with the A320 in 2015. Phase 2: The second phase of the manufacturing process includes converting the commercial aircraft into the LMXT tanker at Lockheed Martin Aeronautics' Marietta, Georgia, facility, which is currently home to the C-130J Super Hercules final production and F-35 Lightning II center wing assembly lines.

10:01 EST Flex LNG falls -6.7% - Flex LNG is down -6.7%, or -$1.40 to $19.46.

10:00 EST Innovid falls -7.5% - Innovid is down -7.5%, or -39c to $4.81.

10:00 EST TDCX rises 11.4% - TDCX is up 11.4%, or $1.53 to $14.90.

09:47 EST Natuzzi falls -7.0% - Natuzzi is down -7.0%, or -79c to $10.46.

09:47 EST Innovid falls -7.7% - Innovid is down -7.7%, or -40c to $4.80.

09:47 EST Ambrx Biopharma rises 8.2% - Ambrx Biopharma is up 8.2%, or 38c to $5.04.

09:42 EST KSCP Stock trading resumes

09:37 EST KSCP Stock trading halted, volatility trading pause

09:31 EST Triumph Group signs MOU with Aerotrax Technologies - Aerotrax Technologies announced the signing of a Memorandum of Understanding with Triumph Group to commercially pilot the Aerotrax Maintenance, Repair and Overhaul Service Management System, enabling real-time data sharing, collaboration, and communication with participating Triumph Group repair stations and customers. The engagement will use Aerotrax's proprietary blockchain-based digital infrastructure to execute repair orders, manage customer requirements, and ensure the seamless exchange of part related data. For a MRO Service Provider, the technology improves quality control, operational efficiency, and provides a differentiated customer experience. As for airlines or integrator customers, the benefits include reduced turn-around-time, which can lead to reduced inventory levels, superior document quality control and tracing, and up to the minute status of "in work" components at the MRO shops.

09:19 EST AmpliTech Group reports 2022 order backlog of $10.5M - Fawad Maqbool, CEO, commented, "AmpliTech has a backlog of $10.5M in orders expected to ship principally in the first half of 2022, versus revenue of $3.5M in the twelve months ended September 30, 2021. This provides a very solid revenue base we are working to grow via the launch of new solutions and expanded sales and marketing outreach. Setting us apart is our industry-leading radio frequency signal processing technologies which enable the movement of data with greater efficiency, improved reliability, reduced power, and lower cost. These performance advantages are of critical importance to satellite communications, 5G connectivity, quantum computing and other services struggling to achieve the far greater data transfer rates they require. Having up-listed to Nasdaq less than a year ago, we are eager to build investor awareness via high quality forums like Little Grapevine."

09:18 EST Carnival announces extension of stock share sale program - On June 28, 2021, Carnival announced that it had filed a prospectus supplement with the United States SEC, under which it may offer and sell shares of its common stock through its agent, BofA Securities, having an aggregate offering price of up to $500M, from time to time through an "at-the-market" equity offering program. As described in the Previous Announcement, Carnival intends to use the net proceeds from the Offering to purchase an equivalent number of Carnival plc ordinary shares and use the remaining net proceeds, if any, from the Offering for general corporate purposes. The Previous Announcement stated that the Share Purchase Program was expected to end no later than January 31, 2022. Today, Carnival Corporation & plc announce an extension of the Share Purchase Program until April 30, 2022, under the same terms. PJT Partners continues serving as independent financial advisor to Carnival Corporation and Carnival plc.

09:17 EST GenTech announces orders for STORM brand - GenTech Holdings grows its retail footprint for new brand STORM with orders from several national retailers and regional health store power houses. STORM is now in an impressive array of retailers both in the US and internationally. With Multiple GNC Franchises picking up the brand with locations in Tampa, Houston, Mississippi and Minnesota, recently added, they are in good company as specialty retail stores across the country are already stocking the brand. NIP Fitness, Total Nutrition, OC Discount and Muscle & Strength are just a handful of those rushing to sign up the brand and are already placing orders. Also, UK and New Zealand distributors are already in the final throws of putting together their orders to take the brand to their territories. The Company launched STORM at the Olympia in Orlando, FL, in October 2021 to great reception from both consumers and retailers alike

09:13 EST Goeasy announces enhancements to securitization, credit facilities - goeasy announced enhancements to its existing revolving securitization warehouse facility and senior secured revolving credit facility. The Company has announced an increase to its Securitization Facility from $600 million to $900 million. The Securitization Facility, which was originally established in December 2020, will continue to be structured by National Bank Financial Markets, with the addition of Bank of Montreal and Royal Bank of Canada as new lenders to the syndicate. The facility will continue to bear interest on advances payable at the rate of 1-month Canadian Dollar Offered Rate plus 185 bps. Based on the current 1-month CDOR rate of 0.52% as of January 28, 2022, the interest rate would be 2.37%. The Company will continue utilizing an interest rate swap agreement to generate fixed rate payments on the amounts drawn and mitigate the impact of increases to interest rates. Proceeds from the Securitization Facility will be used for general corporate purposes, primarily funding the growth of the Company's consumer loan portfolio. The Company also announced an amendment to its Credit Facility, which will decrease from $310 million to $270 million, with the maturity extended to January 27, 2025 and a reduction to the interest rate payable on advances. On lenders prime rate advances, the interest rate payable has been reduced by 125 bps, from the previous rate of Prime plus 200 bps to Prime plus 75 bps. On draws elected to be taken utilizing the Canadian Bankers' Acceptance rate ("BA"), the interest rate payable has been reduced by 75 bps, from the previous rate of BA plus 300 bps to BA plus 225 bps. Based on the current Prime rate of 2.45% and the current 90-day BA rate of 0.50% as of January 28, 2022, the interest rate on the principal amount drawn would be 3.20% or 2.75%, respectively, at the option of the Company. Additionally, the amendment incorporates key modifications including improved advance rates, less restrictive covenants, and a broader syndicate of banks. The amended Credit Facility is underwritten by Bank of Montreal, Royal Bank of Canada, Wells Fargo Bank, CIBC, National Bank of Canada and Toronto-Dominion Bank, and the Company has the ability to utilize an accordion feature to increase the size of the facility by up to an additional $100 million.

09:11 EST Angi services to be available in Walmart stores - Angi (ANGI) is teaming up with Walmart (WMT). Angi's pros will soon be available in nearly 4,000 Walmart stores across all 50 states and nationwide online. This service offering includes over 150 common home projects including flooring, painting, plumbing, electrical, tv mounting, installation and assembly services for furniture and more. Walmart will be Angi's first limited-time exclusive retailer to offer these services. Services can be purchased online or in-store alongside any eligible item or from the Angi dedicated landing page at any time on Walmart.com. "We are pleased to launch Angi with Walmart, a leading global retailer, as our first retail integration," said Oisin Hanrahan, CEO, Angi. "Since the start of the pandemic, the home is in focus and people across the U.S. are doing more home improvement, maintenance and repair work and they are often turning to Walmart to find the tools and materials needed to start those projects. Things like sprucing up an entertaining space by installing a new smart TV, painting a nursery for a family addition, and transforming an outdoor space and adding a patio are now projects that Walmart customers can get done seamlessly with the help of an Angi pro as part of the Walmart shopping experience."

09:09 EST Save Foods' eco crop protection treatment approved for distribution in Peru - Save Foods announced that the company received approval from Peru's Ministry of Agricultural Development and Irrigation to sell its products in Peru. Using its proprietary eco products, Save Foods cuts waste by protecting fresh produce from decay and microbial contamination. Dan Sztybel, Chief Executive Officer of Save Foods, the Company's Israeli subsidiary, commented on the announcement: "Save Foods' treatment helps packing houses to address the growing challenges of exporting fruit and vegetables while maintaining their freshness and reducing waste after an extended export process. Peruvian exporters face this challenge on a daily basis as it can take between three to five weeks to deliver Peruvian produce to the average European retailer. Our treatment fights pathogens, which are largely responsible for decay, and can be used in combination with, or as a replacement for, pesticides that leave chemical residues on fresh produce. This helps packers meet the requirements of the EU's recently established "Farm to Fork Green Deal Initiative" while maintaining high-quality produce."

09:08 EST Bassett Furniture to invest up to $30M in the business in 2022 - The company said, "Looking ahead, we have started a series of initiatives currently underway that are designed to grow Bassett and to make us more competitive in the short- and mid-term. We plan to invest up to $30M in the business in 2022 in the following areas: Technology - Our digital transformation program is well underway, which includes reformatting our business data with a new Product Information Management package and introducing a new website platform this fall. Retail - We plan to open two new format stores in 2022, one of which will be in a new market while the other store will be a reposition of a store in the Dallas market. We also have plans to remodel at least three others. Manufacturing - New advanced machinery purchases are in process for both our North Carolina upholstery operations and our Virginia based woodworking facilities. We have also invested in new material handling equipment to improve the ergonomic environment of our facilities and to further protect our products on their way to our customers. Outdoor - The domestic aluminum outdoor furniture operation that we acquired in Haleyville, Alabama in 2019 has the potential to significantly contribute to our growth plan. We are negotiating to buy the facility and another adjacent building and continue with the upgrade program that is already underway."

09:06 EST Finward Bancorp completes acquisition of Royal Financial - Finward Bancorp, the holding company for Peoples Bank, announced that it has successfully completed the previously announced acquisition of Royal Financial and its wholly-owned Illinois state chartered savings bank subsidiary, Royal Savings Bank, of Chicago, Illinois, in a stock and cash transaction. Simultaneous with the acquisition of Royal Financial by Finward, Royal Savings Bank merged with and into Peoples Bank. Under the terms of the merger agreement, Royal Financial stockholders who owned 101 or more shares of Royal Financial common stock were permitted to elect to receive either 0.4609 shares of Finward common stock or $20.14 in cash, or a combination of both, for each share of Royal Financial common stock owned. Stockholders holding less than 101 shares of Royal Financial common stock will have the right to receive fixed consideration of $20.14 in cash and no stock consideration for each share of Royal Financial common stock. As a result of Royal Financial stockholder stock and cash elections and the related allocation and proration provisions of the merger agreement, Finward expects to issue 795,423 shares of its common stock and pay cash consideration of approximately $18.7M in the Merger, subject to the final accounting being performed by the exchange agent for the merger. Based on the January 28, 2022 closing price of $47.75 per share of Finward common stock, the transaction has an implied valuation of approximately $56.7M. With the completion of the acquisition, Finward will have approximately $2.2B in consolidated assets, $1.4B in loans and $1.9B in deposits. The acquisition will further expand Peoples Bank's retail banking network in the Chicagoland market, bringing the total number of full-service Banking Centers to 30. The banks will ultimately operate under the name Peoples Bank, although the current offices of Royal Savings Bank will continue to operate under that name until the systems integration process is completed in April 2022. As part of the merger, Finward and Peoples Bank have added Robert Youman to their respective boards of directors.

09:03 EST KeyCorp names Helena Haynes-Carter Chief Diversity, Equity and Inclusion Officer - KeyCorp has named Helena Haynes-Carter as Chief Diversity, Equity and Inclusion Officer for the company. In this role, Helena will lead the strategy and tactics to improve the acquisition, development, and retention of diverse talent and suppliers. She most recently served as Senior Director, Global Diversity Equity & Inclusion for UnitedHealth Group. She has also held past roles at organizations including U.S. Bancorp, Rocky Mountain Minority Supplier Development Council, Xcel Energy, and Colorado Housing and Finance Authority.

09:02 EST Community West Bank appoints William Filippin as president, CCO - Community West Bancshares announced that William Filippin, President of Community West Bank, will resume the position of Chief Credit Officer of the Bank, effective February 1, 2022. In this dual role, Filippin will assume all Chief Credit Officer responsibilities while continuing to serve as President. Filippin has been with the Bank since 2015, and prior to becoming President, he served as Chief Administrative and Chief Credit Officer from 2020-2021.

09:00 EST OTR Acquisition Corporation (Class A Stock) trading resumes

08:52 EST PharmaTher treatment for status epilepticus granted FDA orphan designation - PharmaTher's ketamine hydrochloride was granted FDA orphan designation as a treatment for status epilepticus, according to a post to the agency's website. Reference Link

08:45 EST Eve & Co announces shares for debt transaction - Eve & Co announced it has entered into debt settlement agreements with certain directors, officers, employees, and debentureholders whereby it has agreed to settle an aggregate of $657,000 in payables owed to the Parties related to expenses, loans and services rendered to the Company up to January 2022 in exchange for an aggregate of 5,189,606 common shares in the capital of the Company. The Company is proposing to issue the Settlement Shares to settle the Payables in order to preserve cash for general working capital purposes. Pursuant to the terms of the Debt Settlement Agreements, the Company has agreed to issue an aggregate of 908,677 Settlement Shares at a deemed issuance price of $0.12 per Settlement Share in full and final satisfaction of $109,041 of certain trade payables, directors' fees, and salaries and an aggregate of 4,280,929 Settlement Shares at a deemed issuance price of $0.128 per Settlement Share in full and final satisfaction of $547,959 owed to the holders of the Company's outstanding 10% unsecured convertible debentures that were issued on December 11, 2020. Insiders of the Company are expected to receive 1,916,667 Settlement Shares in settlement of $242,500 of debt. Pursuant to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions, the settlement of the Payables will constitute a "related party transaction" as the Insiders are considered to be related parties to the Company. The Company will rely on exemptions from the formal valuation and minority approval requirements of MI 61-101 as the fair market value of the securities to be distributed to, and the consideration received from, the Insiders will not exceed 25% of the Company's market capitalization. The settlement of the Payables has been approved by all of the independent directors of the Company. All securities issued pursuant to the Debt Settlement Agreements will be subject to statutory and TSX Venture Exchange hold periods until the date that is four months and one day from the date of issuance.

08:40 EST Gamida Cell to begin rolling BLA submission for omidubicel - We are pleased that productive interactions with the FDA enable us to initiate a rolling submission of the BLA for omidubicel this quarter and to complete the full BLA submission during the first half of this year," said Julian Adams, Ph.D., Chief Executive Officer of Gamida Cell. "As we advance omidubicel towards potential approval, we will be assessing strategic alternatives for the best way to bring this important therapy to patients, including potential U.S. or global commercialization partnerships. With the strategic steps we are taking, we believe Gamida Cell will be in a stronger position to support omidubicel through the regulatory approval process while we also continue to advance our NK cell pipeline programs, all as intended to serve our goal of providing access to life-saving cell therapies to patients in need." Gamida Cell ended 2021 with approximately $96.1M in cash and cash equivalents. The company expects cash used for ongoing operating activities in 2022 to range from $60M to $70M in cash and cash equivalents based on its current operating plans. The company anticipates that its current cash will support the company's ongoing operating activities into mid-2023, excluding any additional financing or business development activities that may be undertaken. Gamida Cell plans to report its fourth quarter and full-year 2021 financial results on March 16, 2022, at which time the company will provide an update on its 2022 milestones and more detailed financial guidance.

08:38 EST Paya Holdings announces launch of PayaGov - Paya announced the launch of PayaGov, the company's solutions and domain experts serving government agencies, municipalities, and service providers. "The launch is a key milestone in the strategic alignment of Paya's market-leading government and municipality franchises, and reinforces Paya's commitment to, and position in, this key vertical," the company said. As of year-end 2021, PayaGov serves over 2,000 government agencies and municipalities in 24 states, processing over 8 million payments per year, and delivering over $1 billion in revenue to its government and municipal clients. "We are very excited to introduce PayaGov, building on our market-leading franchise and momentum in this key vertical," said Ben Weiner, chief strategy officer at Paya. "The launch marks the full integration of our First Billing Services and Payment Group brands, consolidating our government solutions and expertise to deliver a stronger value proposition to the market. This alignment will serve as a catalyst for greater innovation and service for our clients, as well as a foundation for continued long-term growth."

08:36 EST Comera Life Sciences to become public through OTR Acquisition combination - Comera Life Sciences and OTR Acquisition announced they have entered into a business combination agreement. The transaction is expected to provide Comera with access to the public equity markets and thereby position Comera to accelerate the development and advancement of its internal portfolio of subcutaneous therapeutics incorporating the company's innovative proprietary SQore formulation platform. Following the closing of the transaction, the combined company will continue to operate under the Comera management team. The combined company, Comera Life Sciences, is expected to have a combined implied initial pro forma equity value of approximately $258.4M translating into an enterprise value of approximately $151.3M, with the proposed business combination expected to provide approximately $107M in gross proceeds from the cash held in trust by OTR. All references to available cash from the trust account and retained transaction proceeds are subject to any redemptions by the public stockholders of OTR and payment of transaction fees and expenses. As part of the transaction, all Comera shares owned by Comera's existing equity holders will be converted into common stock of Holdco. At closing, approximately 12.6M shares of common stock of Holdco will be issued to the Comera stockholders at an implied value of $10.00 per share, before fees and expenses. The transaction also includes an earn-out to existing stockholders of Comera, consisting of approximately 3.15M additional shares of Holdco, which will be released to Comera stockholders if Holdco's share price is at or above $12.50 for 20 out of 30 consecutive trading days within two years post-closing. The transaction, which has been unanimously approved by both boards of directors of Comera and OTR, is subject to approval by stockholders of OTR and other customary closing conditions. The holders of a majority of the Comera voting power have approved the transaction. The proposed business combination is expected to be completed in Q2.

08:34 EST Repay Holdings announces David Guthrie as Chief Technology Officer - Repay Holdings announced the addition of David Guthrie to the executive team in the role of Chief Technology Officer . In his role as CTO, Guthrie will focus on bringing the company new capabilities, integrating technologies via mergers and acquisitions, and product development at scale to further strengthen REPAY's role in providing exceptional payment processing solutions. Guthrie brings extensive experience driving technology and product strategies, with a deep understanding of converging internet, communications, web, and software technologies. He joins REPAY from Sharecare, the digital health company that helps people manage all their health in one place, where he was the Chief Information Officer and Chief Information Security Officer. In these dual roles, Guthrie balanced technical understanding and leadership communication to his oversight of security, IT, and M&A assessments for the company. Prior to joining Sharecare, he held leadership roles with various private and public companies, including Chief Technology Officer of MedCast/WebMD with a focus on webmd.com consumer content and delivery technologies, Chief Technology Officer of PGi where he led all global technology ops, R&D, product and the integration of numerous acquired technologies, Chief Product Officer of PatientPoint, partner at Fuqua Ventures, and multiple board and advisory positions for healthcare IT and communication services companies. Throughout his career, his responsibilities have included technology strategy, product management, research and development, technical operations, user experience design, and security.

08:32 EST Viracta Therapeutics doses first patient in Phase 1b/2 Nana-val trial - Viracta Therapeutics announced that the first patient has been dosed in the multinational Phase 1b/2 trial of its all-oral combination product, Nana-val in patients with Epstein-Barr virus-positive - EBV+ - recurrent or metastatic nasopharyngeal carcinoma and other advanced EBV+ solid tumors. The trial is designed to evaluate the safety and preliminary efficacy of Nana-val alone and in combination with the PD-1 inhibitor pembrolizumab. The trial evaluates Nana-val alone and in combination with pembrolizumab. Additionally, patients with other advanced EBV+ solid tumors will be enrolled to receive Nana-val at the RP2D in a Phase 1b dose expansion cohort.

08:31 EST BetMGM retail sportsbook opens at Nationals Park in Washington, D.C. - BetMGM and the Washington Nationals announced the opening of the first retail sportsbook connected to a Major League Baseball stadium. The BetMGM Sportsbook at Nationals Park is open year-round, providing sports fans an innovative entertainment destination to watch and wager on games. Publicly accessible from N Street SE next to Center Field Gate, the new sportsbook features 40 big-screen TVs with live odds boards that update as the action progresses. Visitors can place wagers directly with cashiers at six betting windows or utilize user-friendly betting kiosks. Additionally, the BetMGM Sportsbook offers full-service beverage and dining options.

08:30 EST Citrix trading resumes

08:25 EST OTR Acquisition Corporation (Class A Stock) trading halted, news pending

08:23 EST H2O Innovation receives conditional approval to list on TSX - H2O Innovation announced that it has received conditional approval to list its common shares on the Toronto Stock Exchange. In connection with the listing, the Corporation will apply to voluntarily delist the Common Shares from the TSX Venture Exchange Inc. to be effective as of the date the Common Shares commence trading on the TSX. In connection with the proposed TSX listing, the Corporation has amended its stock option plan to meet TSX standards. Final approval of the TSX listing is subject to the Corporation meeting certain customary conditions required by the TSX. The Corporation expects to satisfy all the requirements of the TSX in the coming weeks and will issue a press release once the TSX confirms the date when trading of the Common Shares is expected to begin on the TSX. Upon listing on the TSX, the Common Shares will continue to trade under the symbol "HEO."

08:21 EST International General Insurance appoints Stav Tsielepis as chief risk officer - International General Insurance announced the appointment of Stav Tsielepis as chief risk officer of the IGI group. Based in the company's London office, Tsielepis will work with the executive team with responsibility for administering IGI's risk management framework including the exposure management and capital modelling functions across the group. He will report to Andreas Loucaides, CEO of IGI UK.

08:18 EST Hoth Therapeutics names John Cirrito, Carla Yuede to Scientific Advisory Board - Hoth Therapeutics announced the addition of John Cirrito, PhD and Carla Yuede, PhD to the company's Scientific Advisory Board. While serving on the Board, Dr. Cirrito and Dr. Yuede will oversee the development of HT-ALZ, an oral therapeutic in development under the 505(b)(2) regulatory pathway for the treatment of Alzheimer's disease and symptoms associated with AD. Hoth currently has a sponsored research agreement with Dr. Cirrito and Dr. Yuede through Washington University to execute preclinical proof of concept studies for HT-ALZ.

08:17 EST Immix Biopharma initiates IMX-110 GMP manufacturing scale-up - Immix Biopharma announced that it has initiated IMX-110 Good Manufacturing Practice scale-up manufacturing, potentially accelerating the timeline to clinical data from two ImmixBio clinical trials planned for 2022: first, planned monotherapy IMX-110 clinical trial in soft tissue sarcoma; second, planned combination IMX-110 + BeiGene anti-PD-1 tislelizumab clinical trial in advanced solid tumors. "Initiating GMP manufacturing 36 days after the closing of our IPO puts us on a path of potentially accelerating our clinical trials," said Ilya Rachman, MD PhD, CEO of ImmixBio. "We believe this step paves the way to execute our planned milestones at an accelerated pace."

08:15 EST GreenBox, convertible note investor collaborate to mitigate conversion risk - GreenBox POS announced that it has entered into an agreement with respect to the $100 million convertible note financing, originally entered into on November 2, 2021, in order to relieve immediate conversion concerns. Under the agreement, as detailed on the Company's simultaneously filed Form 8-K, certain conversion triggers will be extended from February 3rd to May 2, 2022. This 90-day extension offers GreenBox the time to push its business forward toward increased growth, leading to a potentially higher valued stock price, and perhaps, even driving it to a level where the note may be cleared altogether. In the spirit of a mutually beneficial arrangement, GreenBox has agreed to reduce the note principal by $6,000,000, down to $94,000,000 from the original $100,000,000 in consideration of a payment of $6.9 million. Expressing enduring confidence in GreenBox, the investor has agreed to adjust the initial conversion price from $15 to $12, reflecting an adjusted enterprise value of $540,000,000 for the Company, representing a significant premium to the current market cap.

08:13 EST Enphase Energy expands battery storage in Massachusetts - Enphase Energy announced that Enphase installers in Massachusetts have seen an increase in deployments of the Enphase Energy System, powered by IQ Microinverters and IQ Batteries, as extreme weather and power outages continue to impact the state. "We are proud to partner with the best installers in Massachusetts to deploy our industry-leading products so homeowners can truly become resilient and take control over their energy future," said Dave Ranhoff, chief commercial officer at Enphase. "Helping to provide an exceptional customer experience is part of our DNA. The Enphase Energy System, powered by IQ Microinverters and IQ Batteries, has revolutionized home energy and we look forward to continuing to set a high standard with ongoing innovation for years to come."

08:12 EST BigCommerce launches in Germany, Mexico and Spain - BigCommerce announced it has extended its global presence into Germany, Mexico and Spain. With BigCommerce's flexible enterprise-grade ecommerce platform and best-of-breed partner network, local merchants will be able to build, scale and grow their B2C and B2B businesses internationally and leverage industry-leading omnichannel capabilities for marketplace selling to drive revenue. The company's latest expansion comes six months after its successful launch into France, Italy and the Netherlands and marks BigCommerce's official market entry into Latin America.

08:09 EST China Xiangtai Food announces pricing of $16M registered direct offering - China Xiangtai Food announced that it entered into a securities purchase agreement with certain investors to sell up to $16,130,716 of its ordinary shares in a registered direct offering and ordinary share purchase warrants in a concurrent private placement. Under the terms of the securities purchase agreement, the Company has agreed to sell 18,124,400 ordinary shares in a registered direct offering and warrants to purchase 18,124,400 ordinary shares in a concurrent private placement pursuant to an exemption from the registration requirements of the Securities Act of 1933 provided in Regulation S promulgated thereunder. The warrants will be exercisable 60 days from the date of issuance and have an exercise price of US$1.008. The warrants will expire five years from the date of issuance. The purchase price for one ordinary share and one corresponding warrant will be US$0.89. The gross proceeds to the Company are estimated to be US$16,130,716 before deducting placement agent fees and other estimated offering expenses. The Company plans to use the net proceeds from the offering for new business assessment and acquisition, product research and development, marketing and business development, and working capital and general business purposes. The registered direct offering and the concurrent private placement are expected to close on or about February 2, 2022, subject to satisfaction of customary closing conditions. Univest Securities, LLC is acting as the exclusive placement agent for this offering. Ortoli Rosenstadt LLP serves as counsel to the Company, and Hunter Taubman Fischer & Li LLC serves as counsel to Univest Securities, LLC in connection with the offering.

08:08 EST 180 Life Sciences CEO Woody issues letter to stockholders - 180 Life Sciences released the following letter to shareholders from its Chief Executive Officer, Dr. James Woody. "Dear Fellow Shareholders... To begin, I would like to comment on our current share price. On a macro basis, and in general, we are not an anomaly as both the market and the biotech sector have been declining precipitously... While we are not pleased with the recent drop, we have an unfaltering belief in the Company and remain focused on creating fundamental value that we expect will ultimately be reflected over time... Turning your attention to our clinical programs, I would like to recap that in December 2021, we had announced top line results for our Phase 2b trial in early Dupuytren's Contracture, the Company's most advanced clinical program...As previously reported, the study met both primary and secondary endpoints with statistical significance by diminishing the hardness and size of the Dupuytren's nodules, respectively...We believe there is a tremendous market opportunity for treating early-stage Dupuytren's, as we are not aware of any competitors developing such targeted therapies. Based on independent market research conducted by Red Sky Partners on behalf of the Company, the US patient population for Dupuytren's stands at approximately 16 million... In an effort to bring this therapy to market, we have engaged regulatory consultants to assist in discussions with the US Food and Drug Administration and the UK equivalent, the Medicines and Healthcare products Regulatory Agency, to help determine the optimal path forward to a potential regulatory approval. Initial meetings with these regulatory bodies are currently planned for late March or early April of 2022. Our other clinical programs in frozen shoulder and post-operative cognitive delirium are expected to be primarily funded through non-dilutive grants. We currently plan to start the trial for frozen shoulder in Q1/Q2 2022 and for POCD in Q3/Q4 2022. "

08:06 EST U.S. OIG selects Patriot One Technologies' patron screening solution - Patriot One Technologies announced that The U.S. Office of the Inspector General has selected Patriot One's Multi-Sensor Gateway patron screening solution for use at its headquarters building in Washington, D.C. to secure employee entrances. This next-generation patron screening will play an important role in improving employee safety, while providing them with a more convenient experience by eliminating the need for people to empty their pockets or have their bags checked separately.

08:04 EST BRP Group promotes Seth Cohen to General Counsel - BRP Group is pleased to announce that Seth Cohen has been promoted to General Counsel and Corporate Secretary of BRP Group, effective January 31. In his role reporting to Trevor Baldwin, Chief Executive Officer of BRP Group, Mr. Cohen will lead BRP Group's legal, compliance and regulatory function.

08:03 EST Luckin Coffee announces restructuring effective date has occurred - Luckin Coffee announced that pursuant to its previously announced scheme of arrangement, all of the conditions precedent to the effective date of the restructuring contemplated in the Scheme have been satisfied . Accordingly, the Scheme-which governs the restructuring of Luckin Coffee's $460M 0.75% Convertible Senior Notes due 2025-has been substantially consummated and the Restructuring Effective Date has occurred. "Today's development marks the culmination of extraordinary efforts from the Luckin Coffee team and outstanding support from our creditors and stakeholders," said Dr. Jinyi Guo, Chairman and CEO of Luckin Coffee. "We have greatly appreciated the professionalism and guidance of the Joint Provisional Liquidators throughout this pivotal and transformative process. Luckin Coffee is moving forward from a position of financial strength and remains focused on the continued execution of our growth strategy. The Board and management team are confident in our future and our ability to deliver sustainable growth and profitability while providing outstanding products and services to our customers." In aggregate, the Company has issued Scheme Consideration totaling $245.5M of cash, $109.9M of 9.00% Series B Senior Secured Notes due 2027 and 9,235,902 ADSs representing 73,887,216 class A ordinary shares.3The New Notes now represent the Company's only offshore debt securities. The occurrence of the Restructuring Effective Date follows unanimous approval of the Scheme by the voting holders of the Existing Notes, sanction of the Scheme in the Cayman Islands and recognition and enforcement of the Scheme in the United States, each of which was uncontested. The parties to the amended winding up petition dated January 7, 2021 which preceded the application by the Company for the appointment of Joint Provisional Liquidators, expect to apply consensually to the Cayman Court for leave to withdraw or have the Petition dismissed, with resultant discharge of the Joint Provisional Liquidators, as soon as reasonably practicable. Alexander Lawson of Alvarez & Marsal Cayman Islands Limited and Wing Sze Tiffany Wong of Alvarez & Marsal Asia Limited have served as Joint Provisional Liquidators of the Company since July 15, 2020.

08:00 EST Embraer's Beacon maintenance platform selected by Russia's Jet Flight Services - EmbraerX signed an agreement with Jet Flight Service - JFS -, a global MRO service provider headquartered in Russia certified by the European Union Aviation Safety Agency and Russian Federal Agency for Air Transport. This partnership is supporting Jet Flight Service in gaining efficiencies by onboarding their teams into Beacon's multi-sided platform. JFS decided to join the platform aiming to improve coordination during maintenance operations. Incubated by EmbraerX, Embraer's market accelerator for disruptive businesses, Beacon is a maintenance coordination platform designed to connect and synchronize industry resources, the aftermarket supply chain, and aviation services professionals to keep aircraft flying.

07:42 EST Brainsway announces final LCD published on BrainsWay Deep TMS system - BrainsWay announced that a final Local Coverage Determination, LCD, has been published providing coverage applicable to the BrainsWay Deep TMS system for the treatment of obsessive-compulsive disorder, OCD. The final LCD was issued by the Medicare Administrative Contractor, MAC, Palmetto GBA, which covers Medicare patients in Alabama, Georgia, North Carolina, South Carolina, Tennessee, Virginia, and West Virginia. The final LCD was published following a formal meeting hosted by Palmetto last year and a subsequent review period. The formal LCD will be effective on March 13, 2022. "This formal policy issued by Palmetto, one of seven MACs in the U.S., brings the total number of covered lives eligible for Deep TMS OCD coverage to approximately 60 million, an important reimbursement achievement for our company," said Christopher von Jako, Ph.D., President and Chief Executive Officer of BrainsWay. "This final LCD is supported by the large body of compelling clinical evidence demonstrating the meaningful benefits derived by OCD patients from treatment with our innovative Deep TMS technology. We continue to work diligently to secure further coverage policy decisions from additional payors, and believe that, over time, other MACs will issue draft policies for Deep TMS coverage of OCD."

07:41 EST Rezolve appoints Stephen Perry, Derek Smith to board of directors - Rezolve announced the expansion of its board of directors with the addition of two new members, Dr. Stephen Perry and Dr. Derek Smith On December 17, 2021, Rezolve announced that it had entered into a definitive business combination agreement with Armada Acquisition Corp. I (AACI), a publicly traded special purpose acquisition company. Upon closing of the transaction, the combined company's shares are expected to trade on the NASDAQ under the ticker symbol "ZONE". Perry currently serves as a Board member or advisor to a number of disruptive companies in the payments and data analytics sectors, and has served as a Senior Advisor to Rezolve since 2019. Smith spent 16 years with The Economist in various leadership roles, including President of Asia Pacific, and more recently Smith has served as a consultant, advisor and board member for a number of small and medium sized businesses.

07:37 EST Berkshire Grey secures $14M in new orders since November - Berkshire Grey announced it has recently secured $14M in new orders since November 2021. These new orders include $8M of orders from new customers and $6M of follow-on new orders from the Company's anchor accounts. The additional orders reflect growing demand from market-leading retailers, eCommerce providers, package handling companies and third-party logistics companies that rely on Berkshire Grey's AI-enabled robotic solutions to automate and transform their warehouse operations and meet soaring consumer expectations for on-demand order fulfillment. The new orders reinforce the Company's ongoing commercial momentum. In 2021 the Company: Increased orders by $84M, bringing total orders since inception to $200M. Doubled the number of customers year-over-year, including initial orders with new Fortune 100 and global retail brands. Ended the year with $105M of backlog. "We continue to demonstrate strong commercial momentum with these new orders. At $200M in total orders to date, we are proving the value we are delivering to our customers, enabling them to create long term competitive advantage in ecommerce, retail, and logistics, with our AI technology and robotic solutions," said Tom Wagner, CEO of Berkshire Grey.

07:36 EST Rekor Systems CEO issues shareholder letter recapping strategic business plans - Rekor Systems announced that CEO Robert A. Berman, has issued a letter to shareholders recapping strategic business plans and recent advancements that have positioned the Company for future growth. In the letter, Mr. Berman provides an assessment of the unwanted impact that heavy traffic and congestion have had across the United States and how Rekor's solutions can quickly and efficiently address problems in a truly sustainable way. The letter also recaps an unbiased assessment of market of opportunities by KPMG, the launch of intelligent infrastructure projects across multiple states, and insight on a privacy filter developed by the Company that enables sensors to collect and analyze rich data sets that can be securely shared with multiple agencies for use in traffic management, incident response, planning, and maintenance functions. Mr. Berman's letter to shareholders details many commercial and public sector use cases where the strength of Rekor's innovative products and solutions addresses clients' many and diverse business problems. It highlights various business and development opportunities for Rekor's AI software in traffic management and compliance that have allowed the company to develop a single unified platform that can execute multiple client missions and represent significant revenue opportunities for the Company.

07:35 EST Quipt Home Medical announces revocation of management cease trade order - Quipt Home Medical announced that, as a result of the filing of its annual financial statements and management discussion & analysis for the financial years ended September 30, 2021 and 2020, and the CEO and CFO certificates, on January 27, 2022, the management cease trade order issued by the British Columbia Securities Commission on December 30, 2021 has been revoked by the BCSC effective January 28, 2022.

07:34 EST AppHarvest expects to record non-cash charge of $59.9M in Q4 - For the fourth quarter, the company expects to record a non-cash charge of approximately $59.9 million to impair the carrying value of goodwill and definite lived intangible assets related to the recent acquisition of Root AI, an artificial intelligence and robotics company. The impairment reflects current market valuations and strategic investment requirements as the company continues to develop commercial technologies through ATI. The company continues to believe in the strength of ATI to deliver robotics and software solutions to optimize its own high-tech farm network and to serve the broader controlled environment agriculture sector globally. With the advantage of being deployed in AppHarvest's Morehead facility since the acquisition, the company's universal harvesting robot has doubled in its picking capability in that period and the group has developed a farm operations software platform with multiple applications. Both the robotics and software are expected to become revenue-generating in 2023.

07:30 EST Madrigal Pharmaceuticals trading resumes

07:22 EST Crew Energy reports December average production 32,600 boe per day - Crew Energy is pleased to announce it has established a new production record with average volumes estimated at 32,600 boe per day in December 2021, and are providing an operational update confirming that Crew's two-year plan is on track to deliver greater than 20% production per share growth, over 50% Adjusted Funds Flow growth and greater than a 45% reduction in net debt / EBITDA ratio in 2022. Strong Q4 and Start to 2022 Record Average Production: Crew's December average production is estimated at 32,600 boe per day and represents a new record high for the Company. Q4/21 average production is estimated at 29,100 boe per day, ahead of previous guidance of 28,000 to 29,000 boe per day, and an increase of 34% over Q4/20 average production of 21,666 boe per day. Full year 2021 production is estimated to average 26,400 boe per day, near the midpoint of Crew's 26,000 to 27,000 boe per day previous guidance, and a 20% increase over the prior year. Production volumes, based on field estimates, to date in January have averaged approximately 32,500 boe per day. Capital Expenditures and Guidance on Track: While the original plan anticipated the drilling of 26 wells and completion of 21 wells during 2021, the Company elected to complete an additional three Ultra-Condensate Rich wells in Q4/21 to capture the benefit of stronger commodity prices and mitigate the impact of shut-in production from offsetting wells at the 4-21 pad at West Septimus. Capital spending through Q4/21 is estimated at approximately $42M. Full year 2021 net capital expenditures are anticipated at approximately $170M, at the high end of Crew guidance of $150 to $170M, and within the guided range despite completing three additional wells that were not included in the budget. First quarter 2022 production is expected to average 31,000 to 33,000 boe per day. Full year 2022 guidance is reconfirmed, for production to average 31,000 to 33,000 boe per day with capital expenditures of $70 to $95M. Strong Liquids Rich Wells at Greater Septimus: Five liquids rich wells were brought on production at Greater Septimus in Q4/21. Three Extended Reach Horizontal wells on the 4-14 pad were drilled to an average lateral length of 4,140 metres in the Upper Montney "B" zone. They were completed and brought on production into the Septimus gas plant on December 23rd and have now been shut-in while we complete the remaining wells on this pad. After an average of 27 days on production, following a short clean-up period, the three wells on the 4-14 pad were flowing at an average per well sales rate of 2,585 boe per day, comprised of 9,940 mcf per day of natural gas, 750 bbls per day of condensate and 180 bbls per day of ngl's3 Comparative type curves for this pad are available within Crew's updated February 2022 investor presentation available on Crew's website. Two Upper Montney "B" zone wells were completed at Crew's 4-21 pad with an average lateral length of 2,710 metres. After an average of 33 days on production and following a short clean-up period, the wells were flowing at an average per well sales rate of 1,755 boe per day, comprised of 7,070 mcf per day of natural gas, 404 bbls per day of condensate and 174 bbls per day of ngl's3. Comparative type curves for this pad are available within Crew's updated February 2022 investor presentation available on Crew's website. These wells have been shut-in for facilities construction and are expected to resume production by the end of February. Operational Execution a Prime Focus: Currently, Crew has one drilling rig and one fracturing spread in operation. The drilling rig is on the second well on Crew's five-well 4-17 Groundbirch pad, following up on the success of our first three wells that were drilled and completed in 2021. The first three wells at Groundbirch are exceeding Crew's internal type curve with an initial production rate after 90 days average raw gas rate of 9,910 mcf per day. The remaining seven wells on our ten-well 4-14 pad at Greater Septimus are currently being completed with initial production expected late in Q1/22. Leverage Metrics Improving while Retaining Strategic Optionality: Crew has ample liquidity to complete our two-year plan, with leverage metrics expected to continually improve with the Company planning to reduce indebtedness through 20224. Crew's net debt5 to the last twelve-months' EBITDA ratio is budgeted to improve to a targeted 1.3 to 1.5 times at the end of 2022, declining from an estimated 2.5 to 2.7 times at the end of 2021. The Company's Free AFF is targeted at a range of $95M to $140M in 2022 depending on commodity prices. Liquidity can be further enhanced given the Company has an option to dispose of an additional 11.43% working interest in our Greater Septimus facilities located in northeast B.C. for incremental proceeds of up to $37.5M. Crew can elect to exercise this option at any time between now and June of 2023 and have not modeled these proceeds into our current guidance. Focus on Environment, Social and Governance Initiatives: With the sale of our Lloydminster assets in September of 2021, which represented Crew's most emission-intensive asset, approximately 46% of Crew's direct 2020 GHG emissions have been removed and we anticipate the Company's total GHG emissions intensity will be reduced significantly going forward, putting Crew on a path to reach our emissions reduction goals earlier than anticipated. Divesting of these assets sets the stage for Crew to streamline operations and improve efficiencies going forward while also reducing our overall Asset Retirement Obligation liabilities by a targeted 40%, representing approximately $34.5M associated with 609 gross well bores.

07:18 EST Medicenna Therapeutics announces formation of SAB - Medicenna Therapeutics announced the formation of its Scientific Advisory Board, SAB. Chaired by Sergio Quezada, Ph.D., the SAB will work cohesively with management to explore the full potential of Medicenna's Superkine platform. Medicenna's SAB is comprised of: Sergio Quezada, Ph.D., Chairman: Dr. Quezada is a Professor of Cancer Immunology and Immunotherapy at University College London Cancer Institute. Burkhard Becher, Ph.D.: Dr. Becher is a Professor at the University of Zurich where he serves as Chair of the Institute of Experimental Immunology. David Mooney, Ph.D.: Dr. Mooney is the Robert Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a founding core faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University. William Redmond, Ph.D.: Dr. Redmond is Director of the Immune Monitoring Laboratory and Full Member at the Earle A. Chiles Research Institute at the Providence Cancer Institute.

07:16 EST Xeris Biopharma announces commercial availability of Recorlev - Xeris Biopharma announced that Recorlev is now available for prescription. Xeris has also partnered with PantheRx Rare Specialty Pharmacy to provide a customized support and product distribution program, Xeris CareConnection, for members of the Recorlev ecosystem, including patients, caregivers, physicians, and payors.

07:15 EST BrainBox AI announces global distribution agreement with ABB - BrainBox AI announced its global distribution agreement with ABB. ABB will offer BrainBox AI's technology services with a co-branded customer user interface. This step confirms the next phase of the key relationship following the October 28, 2021, Series A funding announcement, wherein ABB participated as lead investor. This agreement demonstrates ABB's clear recognition of the significant capabilities that BrainBox AI's technology offers and the synchrony with its goals to make buildings smarter, safer, and secure while improving energy efficiency and reducing carbon emissions. The continuation of this strategic engagement allows the ABB Building and Home Automation Systems unit to supplement its existing portfolio of digital offerings with BrainBox AI's solution. With BrainBox AI's technology as the driving force, buildings can benefit from up to a 20-40% decrease in their carbon footprint as well as a reduction in heating, ventilation, and air conditioning energy costs of up to 25%. In addition, BrainBox AI's deep learning software increases occupant comfort and extends the life of HVAC equipment without upfront capital expenditure.

07:14 EST Taysha Gene Therapies reports data for high dose cohort, TSHA-120 - Taysha Gene Therapies reported clinical efficacy and safety data for the high dose cohort of 3.5x10 total vg, as well as long-term durability data across all therapeutic doses of TSHA-120 in giant axonal neuropathy, or GAN. The data is as follows: 5-point improvement in the change in rate of decline in MFM32 score for the high dose cohort compared to natural history decline of 8 points by Year 1; 7-point improvement in the change in rate of decline in MFM32 score across all therapeutic dose cohorts compared to natural history decline of 8 points by Year 1; 10-point improvement in the mean change from baseline in MFM32 score across all therapeutic dose cohorts compared to estimated natural history decline of 24 points by Year 3; 26-point improvement in the change from baseline in MFM32 score for the single patient treated with TSHA-120 compared to estimated natural history by Year 5 and confirmed 97% probability of clinically meaningful slowing of 50% or more in disease progression across all therapeutic dose cohorts. Biopsies obtained pre- and post-gene transfer in five of six patient samples analyzed confirmed active regeneration of axons with increased number of regenerative nerve clusters. Preservation of visual acuity across all therapeutic doses compared to progressive loss of visual acuity observed in natural history. Stabilization of retinal nerve fiber layer, or RNFL, thickness and prevention of axonal nerve degeneration compared to diffuse thinning of RNFL observed in natural history. Additionally, 53 patient-years of clinical data support favorable safety and tolerability profile.

07:13 EST Else starts selling on Kroger.com - ELSE NUTRITION HOLDINGS (BABYF) announces that its Plant-Based Complete Nutrition products for Toddler and for Kids are now available on Kroger.com (KR). The products are also available for sale on Kroger-owned Vitacost.com, an E-commerce leader in the healthy/organic foods space.

07:11 EST Farmland Partners completes first farm acquisition of 2022 - Farmland Partners completed its first farm acquisition of 2022, a 177-acre tract in Mercer County, Illinois. The corn and soybean farm was acquired on January 28 for $1.475M, and its current three-year cash lease is expected to yield 3.6% annually. FPI now owns 185 farms in Illinois, spanning 38,343 acres across 19 counties.

07:10 EST Athira Pharma appoints Grant Pickering to board of directors - Athira Pharma (ATHA) announced the appointment of Grant Pickering to its Board of Directors. Mr. Pickering is CEO, co-founder and member of the Board of Directors at Vaxcyte, Inc. (PCVX).

07:10 EST Evogene's Canonic ships first batch of cannabis varieties to Portugal - Canonic, a wholly-owned subsidiary of Evogene, announced that it has shipped a first batch of its unique cannabis varieties to Portugal, following receiving approval to export from the Israeli Ministry of Health and Ministry of Agriculture. As part of its preparations for the planned 2023 commercial launch in Europe, Canonic expects to enter commercial agreements with local growers and manufactures and will work to obtain required regulatory approvals. To this end, the varieties shipped are intended to be grown in semi-commercial scale for lab testing and regulatory examinations, as required by European regulation.

07:09 EST Jushi Holdings launches investor video update series - Jushi Holdings announced that it launched a new investor-focused video series. The series will highlight the Company's current market position, including its industry-leading operational footprint, national expansion plans, and targeted M&A strategy. Viewers will also be introduced to Jushi's leadership team, beginning with Jim Cacioppo, CEO, Chairman and Founder of Jushi.

07:08 EST Altimmune announces FDA clearance of IND of pemvidutide for obesity - Altimmune announced that the U.S. Food and Drug Administration, FDA, has cleared the Company's Investigational New Drug, IND, application for its Phase 2 clinical trial of pemvidutide for obesity. Pemvidutide is an investigational GLP-1/glucagon dual receptor agonist under development for the treatment of obesity and non-alcoholic steatohepatitis. Altimmune expects to initiate the Phase 2 trial in obesity in the first quarter of 2022. The Company previously received IND clearance for pemvidutide in NASH and is currently enrolling subjects with nonalcoholic fatty liver disease in a Phase 1b trial. "This Phase 2 trial in obesity represents an important milestone toward developing a safe and effective treatment option for people with obesity," said Vipin Garg, Ph.D., President and Chief Executive Officer of Altimmune. "Results from a recently completed Phase 1 study of pemvidutide in Australia showed that 12 weekly subcutaneous doses of pemvidutide at the 1.8 mg dose level resulted in an average weight loss of 10.3% in overweight and obese subjects. Importantly, there were no study discontinuations due to adverse events. We believe these results rank among the best in terms of the rate and magnitude of weight loss and tolerability among drugs in development for obesity." The Phase 2 clinical trial will enroll approximately 320 individuals with obesity or who are overweight with at least one obesity-related complication. The primary endpoint of the study is the relative change in body weight at 48 weeks compared to baseline, with additional readouts including metabolic and lipid profiles, cardiovascular measures, and glucose homeostasis. An interim analysis is planned to assess changes in body weight after 24 weeks of treatment, with an expected readout in Q4 2022.

07:07 EST Diversified Healthcare Trust enters into $703M joint venture for 10 properties - Diversified Healthcare Trust announced that it has entered into a $703M joint venture for 10 properties in DHC's Office Portfolio segment with two global institutional investors. The investors acquired a 41% and 39% equity interest in the joint venture for an investment of approximately $100.7M and $95.8M, respectively, and DHC retained a 20% equity interest in the joint venture. The joint venture incurred approximately $456.3 million of secured debt on the properties. The results of operations of the joint venture will be deconsolidated and DHC's remaining 20% equity interest will be accounted for using the equity method. DHC expects to use the cash proceeds from this transaction to fund capital expenditures, to reduce outstanding indebtedness and for other general business purposes. These Office Portfolio segment properties contain an aggregate of approximately 1.1 million square feet and are located in five states. The 10 property portfolio is being sold at approximately $657 per square foot, or a 4.98% capitalization rate based on full year 2021 actual cash NOI. As of September 30, 2021, these properties were 97% occupied for a weighted average remaining lease term of 6.6 years . This transaction is expected to result in a gain on sale of approximately $320M

07:05 EST Daimler Truck N.A., NextEra Energy BlackRock Renewable sign MOU for JV - Daimler Truck North America (DDAIF), NextEra Energy Resources (NEE), LLC and BlackRock Renewable Power (BLK), announced that they have signed a Memorandum of Understanding to lay the foundation for a proposed joint venture to design, develop, install and operate a nationwide, high-performance charging network for medium- and heavy-duty battery electric and hydrogen fuel cell vehicles in the U.S. With the goal of accelerating the rollout of carbon-neutral freight transportation, start of operations for the future JV is planned for 2022. Initial funding is expected to be comprised of approximately $650M divided equally among the three parties. Lack of a publicly available, nationwide electric charging infrastructure for commercial vehicles, especially those used for long-haul freight operations, remains one of the biggest barriers for widespread deployment of electric trucks. With formation of this JV, the three parties will be pooling their resources to address this challenge. The parties plan to build a network of charging sites on critical freight routes along the east and west coasts and in Texas by 2026, leveraging existing infrastructure and amenities while adding complementary greenfield sites to fulfill anticipated customer demand. First phase is set to begin construction in 2023. Initial focus will be on battery electric medium- and heavy-duty vehicles followed by hydrogen fueling stations for fuel cell trucks; the sites will also be available for light-duty vehicles to serve the greater goal of electrifying mobility.

07:04 EST Madrigal announces Phase 3 MAESTRO-NAFLD-1 data on resmetirom - Madrigal Pharmaceuticals announced "positive" topline clinical data from the placebo-controlled, double-blind portion of its Phase 3 MAESTRO-NAFLD-1 safety study of resmetirom. The 52-week study demonstrated that resmetirom was safe and well-tolerated at 80 and 100 mg once a day dosing. Additionally, resmetirom helped patients with presumed non-alcoholic steatohepatitis, NASH, achieve significant, clinically relevant reductions in liver fat and atherogenic lipids. "These positive results from the first of our two Phase 3 MAESTRO trials support our conviction that resmetirom has the potential to be the first medication approved for the treatment of patients with NASH and liver fibrosis. The blinded, placebo-controlled data from MAESTRO-NAFLD-1 reinforce previous positive Phase 2 and open-label Phase 3 safety findings in a much larger population of patients followed for 56 weeks. Rigorous safety evaluation is critical in NASH drug development because of the large numbers of patients with NASH that could be treated with a new medication once FDA approved. The large safety database we are generating through the MAESTRO trials supports our regulatory strategy under Subpart H and reflects our commitment to providing the data necessary for overall benefit-risk assessment," stated Paul Friedman, M.D., Chief Executive Officer of Madrigal.

07:03 EST GrowGeneration acquires Horticultural Rep Group, terms not disclosed - GrowGeneration announced the acquisition of Horticultural Rep Group. HRG is a specialty marketing and sales organization of horticultural products based in Ogden, Utah. HRG represents hundreds of product SKU's for GrowGen and other companies that are popular brands in the hydroponics market. In addition, HRG has participated in the sourcing of products across the horticultural and hydroponics industry. HRG will continue to supply the 800+ retail customers it currently services. HRG generated estimated revenue of $10M in 2021 from sales agent commissions and distribution activity.

07:02 EST Quest Diagnostics, Walmart announce laboratory testing collaboration - Quest Diagnostics (DGX) announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect in collaboration with Walmart. The new solution allows people to take control of their health care and purchase the same high quality laboratory tests ordered by healthcare providers through a consumer-friendly website. This collaboration builds upon a long-standing relationship between Walmart and Quest Diagnostics to broaden access to high quality health services. With this new testing solution, an individual can purchase among more than 50 different tests, including general health, digestive health, allergy, heart health, women's health, and infectious disease. Tests can be purchased at WalmartQuestdirect.QuestDiagnostics.com.

06:58 EST BlackBerry to sell non-core patent assets to Catapult for $600M - BlackBerry announced that it has entered into a patent sale agreement with Catapult IP Innovations, a Delaware company, pursuant to which BlackBerry has agreed to sell substantially all of its non-core patent assets to Catapult for total consideration of $600M. Patents that are essential to BlackBerry's current core business operations are excluded from the transaction. BlackBerry will receive a license back to the patents being sold, which relate primarily to mobile devices, messaging and wireless networking. This transaction will not impact customers' use of any of BlackBerry's products, solutions or services. Catapult is a special purpose vehicle formed to acquire the BlackBerry patent assets. Catapult's principal funding for the acquisition will be a $450M senior secured term loan, for which it has received $400M of conditional commitments from a lending syndicate led by Toronto-based Third Eye Capital that includes a Canadian pension fund. At closing, BlackBerry will receive $450M in cash and a promissory note in the principal amount of $150M. The promissory note will be secured by a second lien on the assets of the purchaser and will be subordinated to the rights of the senior lending syndicate. The promissory note will be payable in five equal annual installments of $30M in cash commencing on the third anniversary of the closing date, provided that the senior loan is not in default. Completion of the transaction is conditional upon, among other things, satisfaction of all regulatory conditions under the Hart-Scott-Rodino Antitrust Improvements Act in the United States and the Investment Canada Act. This process could take up to 210 days.

06:52 EST Eagle Pharmaceuticals expects Landiolol NDA submission in Q2 - Eagle Pharmaceuticals announced that AOP Orphan Pharmaceuticals, member of the AOP Health Group, with whom it entered into a licensing agreement in August 2021, has engaged with the FDA to obtain alignment on the content and format of the pre-clinical and clinical data required to support a new drug application - NDA - seeking approval of Landiolol, a novel therapeutic, for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. In August 2021, Eagle entered into a licensing agreement with AOP Health, a privately owned Austrian company devoted to the treatment of rare and special diseases, for the commercial rights to Landiolol in the U.S. Landiolol is designed for use in emergency, cardiac critical care, operating room, and intensive care settings. It is registered in several European countries for the treatment of non-compensatory sinus tachycardia and tachycardic supraventricular arrhythmias. The drug uses a proprietary dosing algorithm to facilitate the administration. Landiolol is already commercially available in Japan and several European markets.

06:46 EST Reata Pharmaceuticals initiates rolling submission of NDA for omaveloxolone - Reata Pharmaceuticals announced that the company has initiated a rolling submission of a New Drug Application to the U.S. FDA for omaveloxolone for the treatment of patients with Friedreich's ataxia. The rolling submission allows Reata to submit portions of the regulatory application to the FDA for review on an ongoing basis. The company reiterates that it expects to complete the submission of the NDA by the end of the first quarter.

06:38 EST Hexo receives Nasdaq notice of non-compliance - Hexo announced that it received notification from The Nasdaq Stock Market that it is not in compliance with the minimum bid price requirement in Nasdaq Listing Rule 5500(a)(2) for continued listing on the Nasdaq Capital Market, since the closing bid price for the company's common shares listed on Nasdaq was below $1.00 for 30 consecutive trading days. Nasdaq Listing Rule 5550(a)(2) requires the common shares to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that failure to meet such requirement exists if the deficiency continues for a period of 30 consecutive business days.

06:34 EST MediciNova granted new patent for MN-001 and MN-002 in Canada - MediciNova has received a Notice of Allowance from the Canadian Intellectual Property Office for a pending patent application which covers MN-001 - tipelukast - and MN-002 - a major metabolite of MN-001 - for hepatic ballooning. Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than January 2035. The allowed claims cover the use of MN-001 or MN-002 for inhibiting hepatic ballooning. The allowed claims cover a wide range of dosage strengths and dosing frequencies.

06:34 EST L3Harris Technologies sees FY22 operating cash flow $2.4B-$2.5B - Sees FY22 adjusted free cash flow $2.15B-$2.25B. Sees FY22 share repurchases approximately $1.5B.

06:22 EST Transport Canada has active defect investigation into Tesla Model 3, Y vehicles - Transport Canada said via Twitter on Friday that "We have an active defect investigation for performance issues with the heating and cooling system on Tesla Model 3 and Y vehicles in cold weather conditions." Reference Link

06:13 EST Ideaya Biosciences initiates IND-enabling studies for IDE161 - Ideaya Biosciences announced initiation of IND-enabling studies for IDE161, a PARG inhibitor development candidate. The company also exercised its option for an exclusive worldwide license from Cancer Research Technology and University of Manchester. Ideaya is targeting an IND submission for IDE161 in Q4, subject to satisfactory completion of ongoing preclinical and IND-enabling studies.

06:05 EST Leju receives noncompliance notification from NYSE - Leju announced that it has received a letter from the New York Stock Exchange, notifying Leju that it is below compliance standards due to the trading price of Leju's American depositary shares.

05:47 EST Aramark named food and beverage partner by Merlin Entertainments - Merlin Entertainments announced that it has named Aramark as its food and beverage partner for five locations in the UK and two in the US. The locations for the multiyear contract include Alton Towers Resort, Chessington World of Adventures Resort, Thorpe Park Resort, Warwick Castle and Legoland Windsor Resort in the United Kingdom, and Legoland California Resort and Legoland Florida Resort in the United States.

05:18 EST WISeKey says experiencing unprecedented demand, record backlog - Carlos Moreira, WISeKey's founder and CEO noted, "Demand since the beginning of 2021 for our IoT semiconductors products has been unprecedented and has reached a point that we are now sitting on a record backlog of purchase orders totaling $39 million already. Currently we are receiving an average of $1.3 million of new orders per week. While shortages in the semiconductor sector are expected to continue in this coming year so we are working hard with our supply chain team to be able to turn most of this backlog into revenue in 2022, while some delivery schedules run through into 2023." Moreira continued, "Our record backlog of $39 million, which is 500% higher than the backlog at 2020 year-end, has given us a great building block that allows our sales team to focus on new opportunities to expand our customer base and geographic footprint. We are expecting to see a significant increase in the number of customers served by WISeKey in this sector by 2023 / 2024."

05:10 EST Kalera to list on Nasdaq through Agrico Acquisition merger agreement - Kalera and Agrico Acquisition jointly announced that they have entered into a definitive merger agreement. As a result, Kalera will transition from its current Euronext Growth Oslo listing to a publicly listed company with its common shares traded on the Nasdaq stock market. Kalera's current management team and recently appointed interim CEO Curtis McWilliams will continue to oversee the business and use the transaction proceeds to further expand their global network of vertical farms. Kalera and Agrico will merge to create a combined company that will be listed on Nasdaq. The share exchange ratio implies a pro forma equity valuation of the combined company of $375M on a fully diluted basis, assuming no redemptions by shareholders of Agrico. If no public shareholders of Agrico exercise their redemption rights, existing Kalera equity holders will own approximately 52%, and Agrico shareholders would own approximately 42% of the issued and outstanding common stock of the combined company at closing. If some Agrico shareholders redeem their shares, Kalera shareholders would own a higher percentage of the combined company and Agrico shareholders would own a smaller percentage. Kalera and/or Agrico may raise additional capital prior to the closing of the transaction.The transaction, which has been approved by the boards of directors of both of Kalera and Agrico, is expected to close in the second quarter of 2022. The transaction remains subject to approval by both Agrico and Kalera shareholders, as well as other customary closing conditions.